JOHN PETER MCLAUGHLIN

CIK 1277967 · CEO · last filed 2023-05-30

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$397.7K

Companies

6

Total Filings

43

Lifetime Open-Market Net

-$855.8K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LNSR Director 53,631 $5.82 $312.1K $0 5 2023-05-30
RMTI Director 136,974 $0.62 $85.6K $0 4 2021-06-22
PDL BIOPHARMA, INC. (PDLI) Delisted CEO 477,934 -$855.8K 18 2020-12-22
Seagen Inc. (SGEN) Delisted Director 39,400 $228.74 $9.01M $0 10 2016-05-24
Adverum Biotechnologies, Inc. (AAVL) Delisted Director 23,613 $0 4 2016-02-17
ANESIVA, INC. (ANSV) Delisted Chief Executive Officer 118,826 $0 2 2008-02-08

Recent Filings · Page 5 of 5

43 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2008-02-08 ANESIVA, INC. (ANSV) Delisted Grant (A) $0 EDGAR
2007-06-15 Seagen Inc. (SGEN) Delisted Grant (A) $0 EDGAR
2007-03-29 ANESIVA, INC. (ANSV) Delisted Grant (A) +50,000 $0 EDGAR
Showing 4143 of 43
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.